左心室辅助装置植入时二尖瓣反流程度与心肌转录组特征差异相关
该研究在2018年1月至2019年10月期间收集72例耐久性左心室辅助装置(LVAD)植入患者的左心室核心组织,比较术前轻度及以下二尖瓣反流(MR,n=30)与中重度MR(n=42)患者的心肌转录组差异,并与8例无心力衰竭供体心脏对照。结果显示中重度MR组炎症相关基因激活增加、细胞增殖相关基因表达降低,可能对心肌恢复有重要影响。
要点
- 中重度MR组较轻度及以下MR组体重更轻(P=.004),三尖瓣修复更多(P=.043)。
- 与供体心脏相比,轻度及以下MR有3985个差异表达基因,中重度MR有4587个。
- 中重度MR特异性上调炎症基因、下调细胞增殖基因,可能影响心肌恢复。
核心结论
- 耐久性LVAD植入时中重度MR患者心肌炎症相关基因激活增加、细胞增殖相关基因表达降低,可能对心肌恢复有重要影响。
研究设计与样本
- 回顾性研究,2018年1月至2019年10月收集72例耐久性LVAD植入患者的左心室核心组织,并进行RNA测序、Gene Set Enrichment Analysis(GSEA)和Gene Ontology分析,以错误发现率<0.05为显著。
主要发现
- 中重度MR组(n=42)较轻度及以下MR组(n=30)体重更轻(P=.004)且三尖瓣修复更多(P=.043),人口学与合并症无差异。
- 与8例无心力衰竭供体心脏相比,轻度及以下MR有3985个差异表达基因,中重度MR有4587个。
- 轻度及以下MR特异性差异表达基因448个,中重度MR特异性差异表达基因1050个。
- GSEA显示共同调控基因中免疫基因表达增加、收缩与能量相关基因表达降低。
- 中重度MR特异的1050个基因中,炎症相关基因上调、细胞增殖相关基因表达降低。
临床怎么用
- LVAD植入前评估MR程度时,可关注其与心肌炎症及增殖相关转录组特征的关联,以辅助判断心肌恢复潜力。
局限性
- 为回顾性研究,样本量有限(共72例LVAD患者及8例供体心脏),转录组差异与临床结局的因果关系尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We examined for differences in pre-left ventricular assist device (LVAD) implantation myocardial transcriptome signatures among patients with different degrees of mitral regurgitation (MR). METHODS: Between January 2018 and October 2019, we collected left ventricular (LV) cores during durable LVAD implantation (n = 72). A retrospective chart review was performed. Total RNA was isolated from LV cores and used to construct cDNA sequence libraries. The libraries were sequenced with the NovaSeq system, and data were quantified using Kallisto. Gene Set Enrichment Analysis (GSEA) and Gene Ontology analyses were performed, with a false discovery rate <0.05 considered significant. RESULTS: Comparing patients with preoperative mild or less MR (n = 30) and those with moderate-severe MR (n = 42), the moderate-severe MR group weighted less (P = .004) and had more tricuspid valve repairs (P = .043), without differences in demographics or comorbidities. We then compared both groups with a group of human donor hearts without heart failure (n = 8). Compared with the donor hearts, there were 3985 differentially expressed genes (DEGs) for mild or less MR and 4587 DEGs for moderate-severe MR. Specifically altered genes included 448 DEGs for specific for mild or less MR and 1050 DEGs for moderate-severe MR. On GSEA, common regulated genes showed increased immune gene expression and reduced expression of contraction and energetic genes. Of the 1050 genes specific for moderate-severe MR, there were additional up-regulated genes related to inflammation and reduced expression of genes related to cellular proliferation. CONCLUSIONS: Patients undergoing durable LVAD implantation with moderate-severe MR had increased activation of genes related to inflammation and reduction of cellular proliferation genes. This may have important implications for myocardial recovery.
引用
- Duggal NM, Lei I, Wu X, et al. Mitral regurgitation severity at left ventricular assist device implantation is associated with distinct myocardial transcriptomic signatures. J Thorac Cardiovasc Surg. 2021. PMID: 34689984. doi:10.1016/j.jtcvs.2021.08.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。